A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is characterized by an important heterogeneity, reflected by different clinical outcomes and chemoresistance. During carcinogenesis, tumor cells display aberrant glycosylated structures, synthetized by deregulated glycosyltransferases, supporting t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed Abd-El-Halim, Yousra, El Kaoutari, Abdessamad, Silvy, Françoise, Rubis, Marion, Bigonnet, Martin, Roques, Julie, Cros, Jérôme, Nicolle, Rémy, Iovanna, Juan, Dusetti, Nelson, Mas, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379629/
https://www.ncbi.nlm.nih.gov/pubmed/34425307
http://dx.doi.org/10.1016/j.ebiom.2021.103541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379629/
https://www.ncbi.nlm.nih.gov/pubmed/34425307
http://dx.doi.org/10.1016/j.ebiom.2021.103541

Ejemplares similares